Somapacitan

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Somapacitan
Accession Number
DB15093
Type
Biotech
Groups
Investigational
Description

Somapacitan is under investigation in clinical trial NCT01706783 (A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency).

Synonyms
  • NNC0195-0092
Categories
UNII
8FOJ430U94
CAS number
1338578-34-9

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
Cortisone acetateThe serum concentration of the active metabolites of Cortisone acetate can be reduced when Cortisone acetate is used in combination with Somapacitan resulting in a loss in efficacy.
MacimorelinThe therapeutic efficacy of Macimorelin can be decreased when used in combination with Somapacitan.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1Active Not RecruitingTreatmentHealthy Volunteers / Human Growth Hormone Deficiency1
1CompletedTreatmentAdult Onset Growth Hormone Deficiency / Growth Hormone Deficiency in Children / Growth Hormone Disorders2
1CompletedTreatmentAdult Onset Growth Hormone Deficiency / Growth Hormone Deficiency in Children / Growth Hormone Disorders / Healthy Volunteers1
1CompletedTreatmentAdult Onset Growth Hormone Deficiency / Growth Hormone Disorders1
1CompletedTreatmentGrowth Hormone Deficiency in Children / Growth Hormone Disorders1
1CompletedTreatmentHealthy Volunteers1
2Active Not RecruitingTreatmentGrowth Hormone Deficiency in Children / Growth Hormone Disorders1
2Not Yet RecruitingTreatmentShort Stature Children Born Small for Gestational Age (SGA)1
3CompletedTreatmentAdult Onset Growth Hormone Deficiency / Growth Hormone Disorders3
3RecruitingTreatmentGrowth Hormone Deficiency in Children1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on May 20, 2019 08:49 / Updated on May 21, 2019 12:35